Results 61 to 70 of about 1,713,919 (291)

PREDICTION OF ATRIAL FIBRILLATION RECURRENCE IN PATIENTS WITH PERSISTENT ATRIAL FIBRILLATION SUFFERING FROM OBSTRUCTIVE SLEEP APNOEA/HYPOPNOEA SYNDROME

Žurnal Grodnenskogo Gosudarstvennogo Medicinskogo Universiteta, 2019
Background. Untreated obstructive sleep apnoea-hypopnoea syndrome (OSAHS) in atrial fibrillation (AF) patients influences the efficacy of antiarrhythmic drug therapy and reduces electrical cardioversion and catheter ablation success rates.
Balabanovich T. I., Shyshko V. I.
doaj   +1 more source

Development of an international standard set of outcome measures for patients with atrial fibrillation: a report of the International Consortium for Health Outcomes Measurement (ICHOM) atrial fibrillation working group. [PDF]

, 2020
AIMS: As health systems around the world increasingly look to measure and improve the value of care that they provide to patients, being able to measure the outcomes that matter most to patients is vital.
Arbelo, E, Banerjee, A, Bollmann, A, Caffrey-Armstrong, B, Camm, AJ, Cehic, DA, Collins, M, Corbalan, R, Dandamudi, G, Das-Gupta, Z, Dorairaj, P, Fay, M, Goto, S, Granger, CB, Gyorgy, B, Healey, JS, Hendriks, JM, Hills, MT, Hobbs, FDR, Huisman, MV, Jobi-Odeneye, AO, Koplan, KE, Lane, DA, Lewis, WR, Lobban, T, McLeod, CJ, Moseley, S, Seligman, WH, Steinberg, BA, Timmis, A, Van Gelder, IC, Yutao, G   +31 more
core   +4 more sources

Electrical Cardioversion for Wide Complex Tachycardia [PDF]

Cureus, 2019
We present a case of electrical cardioversion used to treat a hemodynamically unstable wide complex tachycardia (WCT). The patient returned to normal sinus rhythm after being cardioverted with 100 joules (J) on the first attempt. He was admitted to the hospital for cardiac evaluation and ultimately discharged home on flecainide and nebivolol after a ...
Roka, Abhishek, Stead, Tej G, Ramlatchan, Sidhartha R, Rubero, Jose A, Ganti, Latha   +4 more
openaire   +2 more sources

Impact of atrial fibrillation on the cardiovascular system through a lumped-parameter approach [PDF]

, 2014
Atrial fibrillation (AF) is the most common arrhythmia affecting millions of people in the Western countries and, due to the widespread impact on the population and its medical relevance, is largely investigated in both clinical and bioengineering ...
Camporeale, Carlo, Guala, Andrea, Ridolfi, Luca, Scarsoglio, Stefania   +3 more
core   +2 more sources

Vernakalant and electrical cardioversion for AF – Safe and effective

International Journal of Cardiology: Heart & Vasculature, 2019
Aims: Rapid restoration of sinus rhythm is an integral part of the management of recent-onset atrial fibrillation. We aimed to assess safety and efficacy of vernakalant, a multi-channel blocking agent, in combination with external electrical ...
Alexander Simon, Jan Niederdoeckl, Karin Janata, Alexander Oskar Spiel, Nikola Schuetz, Sebastian Schnaubelt, Harald Herkner, Filippo Cacioppo, Anton Norbert Laggner, Hans Domanovits   +9 more
doaj   +1 more source

Recurring patterns of atrial fibrillation in surface ECG predict restoration of sinus rhythm by catheter ablation [PDF]

, 2014
Background Non-invasive tools to help identify patients likely to benefit from catheter ablation (CA) of atrial fibrillation (AF) would facilitate personalised treatment planning.
Bourke, John P., Di Marco, Luigi Yuri, Langley, Philip, Raine, Daniel   +3 more
core   +1 more source

Canakinumab after Electrical Cardioversion in Patients with Persistent Atrial Fibrillation: A Pilot Randomized Trial.

Circulation: Arrhythmia and Electrophysiology, 2020
Nearly half of all patients with atrial fibrillation (AF) undergoing electrical cardioversion (ECV) experience AF recurrences within 6 months, even with antiarrhythmic drug treatment.1 As inflammatory biomarkers are associated with AF recurrences ...
P. Krisai, S. Blum, R. Schnabel, C. Sticherling, M. Kühne, S. von Felten, P. Ammann, E. Pruvot, C. Albert, D. Conen   +9 more
semanticscholar   +1 more source

Vernakalant-facilitated electrical cardioversion: comparison of intravenous vernakalant and amiodarone for drug-enhanced electrical cardioversion of atrial fibrillation after failed electrical cardioversion [PDF]

Europace, 2015
Electrical cardioversion is one cornerstone for the rhythm control strategy of atrial fibrillation (AF), which is, however, hampered by immediate AF recurrence (IRAF) or failed electrical cardioversion (FECV). We aimed to investigate the potential role of vernakalant for facilitated electrical cardioversion in cardioversion-resistant AF.The subjects of
Andreas, Müssigbrodt, Silke, John, Jedrzej, Kosiuk, Sergio, Richter, Gerhard, Hindricks, Andreas, Bollmann   +5 more
openaire   +2 more sources

The relationship of renal function to outcome: A post hoc analysis from the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation (ENSURE-AF) study. [PDF]

, 2017
The ENSURE-AF study (NCT 02072434) of anticoagulation for electrical cardioversion in nonvalvular atrial fibrillation (NVAF) showed comparable low rates of bleeding and thromboembolism between the edoxaban and the enoxaparin-warfarin treatment arms. This
Al-Saady, N, Banach, M, Ezekowitz, MD, Goette, A, Lip, GYH   +4 more
core   +2 more sources

Effect of sotalol on heart rate, QT interval, and atrial fibrillation cycle length in horses with atrial fibrillation [PDF]

, 2018
Background: Based on its pharmacokinetic profile and electrophysiological effects in healthy horses, sotalol potentially could be used as a long-term PO antiarrhythmic drug in horses.
Anderson, Barrell, Brakel, Broux, Broux, Campbell, Clercq, Clercq, Clercq, Decloedt, Decloedt, Decloedt, Deem, Dufourni, Haugaard, Heliczer, January, Kerin, Lafuente-Lafuente, Loon, Mansour, McGurrin, Meurs, Milan, Pedersen, Rasmussen, Reef, Reef, Verheyen, Wang, Wijffels, Wijffels   +31 more
core   +2 more sources